S&P 500 Futures
(0.11%) 5 333.25 points
Dow Jones Futures
(0.03%) 40 148 points
Nasdaq Futures
(0.20%) 18 672 points
Oil
(-0.44%) $79.71
Gas
(0.95%) $2.65
Gold
(1.13%) $2 444.70
Silver
(3.15%) $32.25
Platinum
(0.05%) $1 090.50
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.10%) $10.67
USD/GBP
(0.02%) $0.787
USD/RUB
(-0.65%) $90.38

Realtime updates for Freeline Therapeutics [FRLN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated16 Feb 2024 @ 15:37

0.15% $ 6.49

Live Chart Being Loaded With Signals

Commentary (16 Feb 2024 @ 15:37):

Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases...

Stats
Today's Volume 5 349.00
Average Volume 28 144.00
Market Cap 28.28M
EPS $0 ( 2024-05-06 )
Next earnings date ( $0 ) 2024-08-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.569
ATR14 $0.0640 (0.99%)

Volume Correlation

Long: -0.38 (neutral)
Short: 0.00 (neutral)
Signal:(61.011) Neutral

Freeline Therapeutics Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Freeline Therapeutics Correlation - Currency/Commodity

The country flag -0.16
( neutral )
The country flag 0.50
( neutral )
The country flag -0.74
( moderate negative )
The country flag 0.65
( moderate )
The country flag 0.16
( neutral )
The country flag 0.60
( weak )

Freeline Therapeutics Financials

Annual 2022
Revenue: $0
Gross Profit: $-1.74M (0.00 %)
EPS: $-22.52
FY 2022
Revenue: $0
Gross Profit: $-1.74M (0.00 %)
EPS: $-22.52
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-3.93
FY 2020
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-6.81

Financial Reports:

No articles found.

Freeline Therapeutics Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Freeline Therapeutics

Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in Phase 1/2 clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in Phase 1/2 clinical trial for the treatment of Fabry disease; and FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease and is under Phase 1/2 clinical trial. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators